Patent Number | Title | Applicant | Opposition Date |
---|---|---|---|
EP3209295 | Methods Of Treating Ocular Conditions | OYSTER POINT PHARMA, INC. | Sep 9, 2021 |
EP3281664 | Nasal Delivery Devices | OPTINOSE AS | Aug 18, 2021 |
EP3515451 | Pharmaceutical Composition | MEXICHEM FLUOR S.A. DE C.V. | Aug 4, 2021 |
EP2136865 | Nasal Delivery | OPTINOSE AS | Jun 8, 2021 |
EP3199193 | Method For Measuring Flow Features In An Inhaler, Inhaler And System | NOVARTIS AG | May 26, 2021 |
EP3383366 | Pharmaceutical Composition | MEXICHEM FLUOR S.A. DE C.V. | Dec 23, 2020 |
EP3191081 | Formulation Comprising Glycopyrrolate, Method And Apparatus | VECTURA LIMITED | Dec 22, 2020 |
EP2957551 | Dry Powder Formulations Comprising Vilanterol | ARVEN ILAC SANAYI VE TICARET A.S. | Oct 1, 2020 |
EP2957552 | Vilanterol Formulations | ARVEN ILAC SANAYI VE TICARET A.S. | Oct 1, 2020 |
EP2890437 | Aerosol Inhalation Device | CHIESI FARMACEUTICI S.P.A. | Sep 18, 2020 |
Feel free to send us a message here and we will get back to you